Aviva
IRMD icon

Aviva’s iRadimed IRMD Stock Holding History

Aviva’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
4,660
+257
+6% +$23.4K ﹤0.01% 767
2026
Q1 		$424K Sell
4,403
-937
-18% -$93.7K ﹤0.01% 766
2025
Q4 		$519K Buy
+5,340
New +$458K ﹤0.01% 721
2024
Q4 		– Sell
-4,418
Closed -$222K – 878
2024
Q3 		$222K Sell
4,418
-393
-8% -$18.1K ﹤0.01% 862
2024
Q2 		$211K Buy
+4,811
New +$205K ﹤0.01% 900
2022
Q3 		– Sell
-61,259
Closed -$2.08M – 1033
2022
Q2 		$2.08M Buy
61,259
+47,159
+334% +$1.69M 0.01% 783
2022
Q1 		$632K Buy
+14,100
New +$652K ﹤0.01% 1018

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aviva's IRMD Position: Q2 2026 in Review

Aviva increased its iRadimed (IRMD) stake by 5.8% in Q2 2026, buying an estimated $23.4K and bringing the position to 4,660 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Aviva first reported a position in IRMD in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.08M in Q2 2022. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Aviva held 4,660 shares of iRadimed worth $445K as of Q2 2026.
  • Aviva bought 257 iRadimed shares in Q2 2026, an estimated $23.4K.
  • iRadimed made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #767 holding.
  • Aviva first reported a position in iRadimed in Q1 2022 and has held it in 7 quarters since.
  • Aviva's iRadimed position peaked at $2.08M in Q2 2022.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.